NeutriSci International (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) this morning announced that it has entered into a major research and development (R&D) Memorandum of Understanding (“MOU”) with Scientus Pharma Inc. In accordance of the terms set forth in the MOU, the two companies have agreed to share their technologies to develop, test, produce, and distribute a medical cannabinoid product for current retail distribution networks throughout Canada. “This Scientus Pharma partnership helps position us at the forefront of developing new and innovative cannabinoid based medical products in Canada. Scientus Pharma, along with its existing partnerships, is sure to be a dominant player in the cannabis space in Canada. Through a collaborative effort, we will incorporate NeutriSci’s IP, technology and ingredients with Scientus’ expertise, proprietary technical know-how, and resources. By leveraging both parties existing partnerships, we will be positioned to offer the national retail consumer a safe, effective, dose controlled product that completes our ‘plant to blood stream’ strategy,” NeutriSci president Glen Rehman stated in the news release.
To view the full press release, visit http://nnw.fm/Gq53L
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on increasing the size of its existing national retail network in Canada by building sustainable sales models with convenience, chain drug, mass market and supermarket retailers for neuenergy® and new novel ingredients for product distribution. The company also continues to develop emerging sales channels in the US, Europe and Asia. For more information, visit the company’s website at www.NeutriSci.com.
More from NetworkNewsBreaks
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information please visit https://www.NetworkNewsWire.com